Northern Trust’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.75M | Sell |
396,067
-37,469
| -9% | -$202K | ﹤0.01% | 3044 |
|
|
2025
Q4 | $2.76M | Buy |
433,536
+1,794
| +0.4% | +$12.5K | ﹤0.01% | 2806 |
|
|
2025
Q3 | $4.03M | Buy |
431,742
+24,251
| +6% | +$245K | ﹤0.01% | 2629 |
|
|
2025
Q2 | $5.87M | Buy |
407,491
+9,422
| +2% | +$93K | ﹤0.01% | 2381 |
|
|
2025
Q1 | $2.75M | Sell |
398,069
-31,804
| -7% | -$200K | ﹤0.01% | 2750 |
|
|
2024
Q4 | $2.28M | Buy |
429,873
+52,170
| +14% | +$286K | ﹤0.01% | 2953 |
|
|
2024
Q3 | $1.38M | Buy |
377,703
+269,817
| +250% | +$849K | ﹤0.01% | 3211 |
|
|
2024
Q2 | $295K | Buy |
107,886
+7,568
| +8% | +$25.3K | ﹤0.01% | 3709 |
|
|
2024
Q1 | $349K | Buy |
100,318
+6,234
| +7% | +$11.5K | ﹤0.01% | 3688 |
|
|
2023
Q4 | $135K | Hold |
94,084
| – | – | ﹤0.01% | 4037 |
|
|
2023
Q3 | $137K | Sell |
94,084
-630
| -0.7% | -$984 | ﹤0.01% | 3931 |
|
|
2023
Q2 | $149K | Sell |
94,714
-265
| -0.3% | -$395 | ﹤0.01% | 3928 |
|
|
2023
Q1 | $145K | Buy |
94,979
+4,642
| +5% | +$8.26K | ﹤0.01% | 3970 |
|
|
2022
Q4 | $152K | Hold |
90,337
| – | – | ﹤0.01% | 3970 |
|
|
2022
Q3 | $111K | Hold |
90,337
| – | – | ﹤0.01% | 4081 |
|
|
2022
Q2 | $151K | Sell |
90,337
-338,480
| -79% | -$662K | ﹤0.01% | 4022 |
|
|
2022
Q1 | $1.05M | Sell |
428,817
-20,645
| -5% | -$56.4K | ﹤0.01% | 3397 |
|
|
2021
Q4 | $1.68M | Buy |
449,462
+3,033
| +0.7% | +$16.4K | ﹤0.01% | 3311 |
|
|
2021
Q3 | $2.8M | Sell |
446,429
-27,340
| -6% | -$225K | ﹤0.01% | 3097 |
|
|
2021
Q2 | $4.67M | Buy |
473,769
+29,635
| +7% | +$258K | ﹤0.01% | 2874 |
|
|
2021
Q1 | $4.15M | Sell |
444,134
-33,388
| -7% | -$265K | ﹤0.01% | 2864 |
|
|
2020
Q4 | $2.29M | Sell |
477,522
-7,536
| -2% | -$36.7K | ﹤0.01% | 3131 |
|
|
2020
Q3 | $1.95M | Sell |
485,058
-20,285
| -4% | -$97.9K | ﹤0.01% | 3079 |
|
|
2020
Q2 | $2.32M | Buy |
505,343
+12,542
| +3% | +$56.2K | ﹤0.01% | 2962 |
|
|
2020
Q1 | $1.61M | Buy |
492,801
+28,288
| +6% | +$109K | ﹤0.01% | 2980 |
|
|
2019
Q4 | $2M | Buy |
464,513
+18,720
| +4% | +$66.5K | ﹤0.01% | 3130 |
|
|
2019
Q3 | $1.75M | Buy |
445,793
+28,882
| +7% | +$123K | ﹤0.01% | 3172 |
|
|
2019
Q2 | $1.94M | Buy |
416,911
+3,090
| +0.7% | +$13.2K | ﹤0.01% | 3096 |
|
|
2019
Q1 | $1.73M | Buy |
413,821
+2,385
| +0.6% | +$8.6K | ﹤0.01% | 3162 |
|
|
2018
Q4 | $1.41M | Buy |
411,436
+5,009
| +1% | +$17.4K | ﹤0.01% | 3226 |
|
|
2018
Q3 | $1.74M | Buy |
406,427
+287,127
| +241% | +$1.23M | ﹤0.01% | 3276 |
|
|
2018
Q2 | $443K | Buy |
119,300
+63,398
| +113% | +$241K | ﹤0.01% | 3633 |
|
|
2018
Q1 | $235K | Buy |
55,902
+14,297
| +34% | +$74.9K | ﹤0.01% | 3781 |
|
|
2017
Q4 | $245K | Buy |
41,605
+950
| +2% | +$5.13K | ﹤0.01% | 3749 |
|
|
2017
Q3 | $175K | Sell |
40,655
-2,233
| -5% | -$8.16K | ﹤0.01% | 3829 |
|
|
2017
Q2 | $164K | Sell |
42,888
-248,311
| -85% | -$787K | ﹤0.01% | 3862 |
|
|
2017
Q1 | $783K | Sell |
291,199
-1,080
| -0.4% | -$3.06K | ﹤0.01% | 3429 |
|
|
2016
Q4 | $967K | Buy |
292,279
+694
| +0.2% | +$1.89K | ﹤0.01% | 3358 |
|
|
2016
Q3 | $869K | Sell |
291,585
-941
| -0.3% | -$3.46K | ﹤0.01% | 3384 |
|
|
2016
Q2 | $1.21M | Buy |
+292,526
| New | +$1.38M | ﹤0.01% | 3288 |
|
Other funds holding NAGE
SW
VCM
TCM
